(Q41005386)

25 September 2017

title

Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. (English)

1 reference

25 September 2017

0 references

Suo Z

1

1 reference

25 September 2017

Tan J

2

1 reference

25 September 2017

Placzek A

3

1 reference

25 September 2017

Crawford F

4

1 reference

25 September 2017

Fang C

5

1 reference

25 September 2017

Mullan M

6

1 reference

25 September 2017

publication date

1 October 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

807

1 reference

25 September 2017

issue

1-2

1 reference

25 September 2017

page(s)

110-117

1 reference

Inflammation and Alzheimer disease

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Cytokines in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Amyloid-beta protein angiopathies masquerading as Alzheimer's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

The CD40 ligand. At the center of the immune universe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Molecular aspects of inflammatory and immune responses in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

CD40-CD40L interactions in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

CD40 and its ligand in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Permeability of the blood-brain and blood-spinal cord barriers to interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Systemic cytokine administration can affect blood-brain barrier permeability in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Studies of neuroimmune markers in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Rapid degeneration of cultured human brain pericytes by amyloid beta protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

An improved cell-ELISA for the differential screening of antibodies against cell surface molecules of viable adherent Schwann cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Immune reactions associated with cerebral amyloid angiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Vascular basement membrane pathology and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900780-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(98)00780-X

1 reference

25 September 2017

1 reference